Delivery Order SPE2DB20D2104-SPE2DB25FMLEQ
Award Date
3/17/25
Potential Completion Date
3/18/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,557.54, is for the provision of Colestipol HCl 1 GM Tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4,566,053,970 tablets of Colestipol HCl 1 g. The contract is a firm-fixed-price delivery order with a ceiling value of $2,941.44 and a period of performance through October 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Colestipol HCl 1 GM Tablets in quantities of 120s. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,069.23 and a period of performance through April 15, 2025. This contract award is not designated as a set-aside. Amerisourcebergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,677.20, is for the delivery of Colestipol HCL 1 GM Tablet 120S, a medication used to treat high cholesterol. The contract has an ultimate completion date of February 12, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Colestipol HCl 1 GM tablets. The contract is a Delivery Order valued at $7,352.07 with a firm fixed price, and has an ultimate completion date of July 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $1,321.02 and runs through January 29, 2025. It is not designated as a set-aside contract. The award is for the delivery of COLESTIPOL HCL 1 GM TABLET 120S, a pharmaceutical product, to support military and federal healthcare programs. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,348.33 firm fixed price contract is for the delivery of 4,564,286,736 colestipol hydrochloride 1 gram tablets. This award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, to provide a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a Delivery Order contract valued at $1,544.56 for the supply of Colestipol HCL 1 GM Tablets. The award is not associated with a set-aside program and appears to be an open competition contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $3,221.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of Colestipol Hydrochloride 1 gram tablets, a medication used to manage high cholesterol levels. The contract has an ultimate completion date of March 3, 2025 and uses a Firm Fixed Price pricing structure. AmerisourceBergen holds a...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, a delivery order valued at $2,505.62, is for the provision of Colestipol HCl 1 GM tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a firm fixed price award and has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on this...